1
|
Adu MK, da Luz Dias R, Obuobi-Donkor G, Ezeanozie N, Sridharan S, Morrison J, Simon P, Taylor B, MacKinnon M, Gossen S, Awara M, White M, Shalaby R, Agyapong B, Eboreime E, Wang J, Feng C, Wozney L, Koto P, Warford J, Murphy GT, Agyapong VIO. Reducing wait times and avoiding unnecessary use of high-cost mental health services through a Rapid Access and Stabilization Program: protocol for a program evaluation study. BMC Health Serv Res 2024; 24:247. [PMID: 38413957 PMCID: PMC10898149 DOI: 10.1186/s12913-024-10697-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Accepted: 02/08/2024] [Indexed: 02/29/2024] Open
Abstract
BACKGROUND Emergency psychiatric care, unplanned hospital admissions, and inpatient health care are the costliest forms of mental health care. According to Statistics Canada (2018), almost 18% (5.3 million) of Canadians reported needing mental health support. However, just above half of this figure (56.2%) have reported their needs were fully met. In light of this evidence there is a pressing need to provide accessible mental health services in flexible yet cost-effective ways. To further expand capacity and access to mental health care in the province, Nova Scotia Health has launched a novel mental health initiative for people in need of mental health care without requiring emergency department visits or hospitalization. This new service is referred to as the Rapid Access and Stabilization Program (RASP). This study evaluates the effectiveness and impact of the RASP on high-cost health services utilization (e.g. ED visits, mobile crisis visits, and inpatient treatments) and related costs. It also assesses healthcare partners' (e.g. healthcare providers, policymakers, community leaders) perceptions and patient experiences and satisfaction with the program and identifies sociodemographic characteristics, psychological conditions, recovery, well-being, and risk measures in the assisted population. METHOD This is a hypothesis-driven program evaluation study that employs a mixed methods approach. A within-subject comparison (pre- and post-evaluation study) will examine health services utilization data from patients attending RASP, one year before and one year after their psychiatry assessment at the program. A controlled between-subject comparison (cohort study) will use historical data from a control population will examine whether possible changes in high-cost health services utilization are associated with the intervention (RASP). The primary analysis involves extracting secondary data from provincial information systems, electronic medical records, and regular self-reported clinical assessments. Additionally, a qualitative sub-study will examine patient experience and satisfaction, and health care partners' impressions. DISCUSSION We expect that RASP evaluation findings will demonstrate a minimum 10% reduction in high-cost health services utilization and corresponding 10% cost savings, and also a reduction in the wait times for patient consultations with psychiatrists to less than 30 calendar days, in both within-subject and between-subject comparisons. In addition, we anticipate that patients, healthcare providers and healthcare partners would express high levels of satisfaction with the new service. CONCLUSION This study will demonstrate the results of the Mental Health and Addictions Program (MHAP) efforts to provide stepped-care, particularly community-based support, to individuals with mental illnesses. Results will provide new insights into a novel community-based approach to mental health service delivery and contribute to knowledge on how to implement mental health programs across varying contexts.
Collapse
Affiliation(s)
- Medard K Adu
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Raquel da Luz Dias
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Gloria Obuobi-Donkor
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Ngozi Ezeanozie
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada
| | - Sanjana Sridharan
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada
| | - Jason Morrison
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada
| | - Patryk Simon
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada
| | - Bryanne Taylor
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada
| | - Monica MacKinnon
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada
| | - Shiloh Gossen
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada
| | - Mahmoud Awara
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada
| | - Mattew White
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada
| | - Reham Shalaby
- Department of Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
| | - Belinda Agyapong
- Department of Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
| | - Ejemai Eboreime
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
| | - JianLi Wang
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
- Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Cindy Feng
- Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Lori Wozney
- Mental Health and Addictions Program, IWK Health, Halifax, NS, Canada
| | - Prosper Koto
- Research, Innovation and Discovery, Nova Scotia Health, Halifax, NS, Canada
| | - Jordan Warford
- Research, Innovation and Discovery, Nova Scotia Health, Halifax, NS, Canada
| | | | - Vincent Israel Opoku Agyapong
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.
- Mental Health and Addictions Program, Nova Scotia Health, Halifax, NS, Canada.
| |
Collapse
|